The study is to determine the long-term outcome of patients with coronary triple vessels disease (TVD) in the real world of China, by three different treatment strategies: percutaneous coronary intervention (PCI), Coronary artery bypass graft (CABG) or optimal medication therapy (OMT).
About 10,000 participants will be enrolled into this retrospective study. Study coordinators will include both men and women over the age of 18 who had angiographic proved triple-vessel disease in a 15 years long-term. Detailed procedural data will be obtained by the study coordinator and local principal investigator. These data will be entered into the electronic data capture system. Participants will have telephone follow-up interviews conducted by the centralized follow-up center at Fuwai Hospital.
Study Type
OBSERVATIONAL
Enrollment
10,000
Fuwai Hospital
Beijing, Beijing Municipality, China
RECRUITINGAll-cause mortality
The mortality due to any cause
Time frame: Through study completion, an average of 5 year
Major adverse cardiac and cerebrovascular event
The incidence rate of major adverse cardiac and cerebrovascular event (MACCE), which is a combination of all-cause death, myocardial infarction, stroke and repeat revascularization
Time frame: Through study completion, an average of 5 year
Myocardial infarction
The Incidence rate of myocardial infarction, including ST elevation myocardial infarction and non-ST elevation myocardial infarction
Time frame: Through study completion, an average of 5 year
Stroke
The incidence rate of stroke, including cerebral infarction and hemorrhage
Time frame: Through study completion, an average of 5 year
Repeat revascularization
The incidence rate of repeat revascularization, including target vessel revascularization and non-target vessel revascularization
Time frame: Through study completion, an average of 5 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.